Ignota Labs
Ignota Labs is an AI-driven drug turnaround company focused on rescuing promising but failing drugs that were abandoned due to safety issues. Their proprietary AI model, SAFEPATH, uses deep learning, bioinformatics, and cheminformatics to identify the mechanisms of toxicity, predict effects on the human body, and balance these with therapeutic effectiveness. By analyzing historically failed clinical trials and internal projects, Ignota Labs builds a pipeline of matured assets, aiming to bring more treatments to patients faster by re-engineering and reviving therapies that would otherwise be shelved. This approach significantly reduces development timelines and costs, potentially transforming patient care with life-saving treatments.
Ignota Labs
Ignota Labs is an AI-driven drug turnaround company focused on rescuing promising but failing drugs that were abandoned due to safety issues. Their proprietary AI model, SAFEPATH, uses deep learning, bioinformatics, and cheminformatics to identify the mechanisms of toxicity, predict effects on the human body, and balance these with therapeutic effectiveness. By analyzing historically failed clinical trials and internal projects, Ignota Labs builds a pipeline of matured assets, aiming to bring more treatments to patients faster by re-engineering and reviving therapies that would otherwise be shelved. This approach significantly reduces development timelines and costs, potentially transforming patient care with life-saving treatments.
